Articles

Editor's Page

• Retina 2012: The Innovations Continue

  By Robert L. Avery, MD; and Allen C. Ho, MD

News Feature

• Researchers Decipher the Retina’s Neural Code to Create Novel Prosthetic Device

  This strategy may have the capacity to restore normal or near-normal vision in patients with retinal degenerative diseases.

  By Callan Navitsky, Associate Editor

Business of Retina
Pennsylvania Avenue Updates

• Opportunities and Risks in Health Care Reform

  ACOs, CINs, insurance exchanges, and other future possibilities.

  By Paul Sternberg, MD

Fellows’ Focus

• Surgical Tips for the Beginning Vitreoretina Fellow: How to Get the Best View During Surgery

  interview with Andre J. Witkin, MD; Joseph Maguire, MD; and Sunir Garg, MD

Clinical Trials for the Retina Specialist

• Adopting and Adapting Imaging Tools for Clinical Use

  By Aron Shapiro and Ashley Lafond

Retina Surgery
Retina Pearls

• Chandelier Lighting During Vitreoretinal Surgery

  This form of endoillumination may be beneficial in several surgical scenarios.

  By Matthew T. Witmer, MD; and R.V. Paul Chan, MD

Global Perspectives

• Uses of Steroids in Vitreoretinal Surgery

  By Stanislao Rizzo, MD; and Francesco Barca, MD

Oncology
Case Reports in Ocular Oncology

• Management of Advanced Retinoblastoma With Intraarterial Chemotherapy

  By Marina L. Reppucci, BA; Enzo M. Fulco, MD; and Carol L. Shields, MD

Cover Stories

• A Changing Treatment Paradigm for Vitreomacular Adhesion

  An interview with Julia A. Haller, MD

• A Novel Intravitreal Injection System

  The Guarded Injection Device provides an extra layer of protection for injections without a lid speculum.
  Reviewed by Alexander M. Eaton, MD

• A Microscope-Integrated OCT System for True Intrasurgical OCT Acquisition

  Intraoperative OCT may introduce new surgical techniques and improve understanding of surgical outcomes.

  By Paul Hahn, MD, PhD; and Cynthia A. Toth, MD

• Advances Reported at ARVO for the Genetics of AMD

  By Alan Franklin, MD, PhD

• Oral Danazol for DME

  By David Bar-Or, MD; Gregory Thomas, BS; Kristin Salottolo, MPH; Alessandro Orlando, MPH; and Vaughan Clift, MD

• Stereotactic Radiotherapy: Results of the INTREPID Study

  Treatment reduced the need for anti-VEGF injections over 1 year.

  By Timothy L. Jackson, PhD, FRCOphth

• Integrin Peptide Therapy

  A new class of treatment for patients with vascular eye disease.
  Reviewed by David Boyer, MD

• Peripheral Ischemia and Rebound Edema in RVO

  In some patients, a different approach may be needed to break the rebound cycle.

  By Michael A. Singer, MD; Colin S. Tan, MBBS, FRCSEd (Ophth), MMed (Ophth); and SriniVas R. Sadda, MD

Ocular Oncology

• The Management of Intraocular Lymphoma R esistant to Intravitreal Methotrexate Injection

  In a patient who presented with asymmetric involvement in both eyes, each eye responded to different management strategies.

  By Pradeep Venkatesh, MD; Varun Gogoi, MD; Sumit Khanduja, MD; Lalit Kumar, MD; and Satpal Garg, MD

Retinal Imaging

• The Versatility of SD-OCT in Patient Screening

  The use of this imaging modality has become more widespread.

  By Urs Vossmerbaumer, MD, PD, MSc, FEBO, DIU

Departments

• Innovations

• 5Q With William Tasman, MD

  Dr. Tasman, the Founder of Mid Atlantic Retina, practices at Wills Eye Institute, where he served as Ophthalmologist-in-Chief for 22 years. He is currently Professor and Emeritus Chairman of Ophthalmology at Jefferson Medical College in Philadelphia.

View All News >